DarioHealth (DRIO) Tops Q1 EPS by 12c, Revenues Miss

Go back to DarioHealth (DRIO) Tops Q1 EPS by 12c, Revenues Miss

DarioHealth Reports First Quarter 2021 Results and Operational Highlights

May 17, 2021 4:30 PM EDT

NEW YORK, May 17, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter of 2021 and provided a corporate and commercial update.

"During the first quarter, we delivered exceptional financial and operating results, driven by balanced contribution from organic growth and the acquisition... More